Pathology of Hypertension Flashcards
Hypertension – morphology
- Large/medium arteries:
- Small arteries/arterioles:
-
Large/medium arteries:
- Accelerated atherogenesis
- Degenerative changes in vascular walls
- Increased risk of aortic dissection & cerebrovascular hemorrhage
-
Small arteries/arterioles:
- Hyaline arteriolosclerosis
- Hyperplastic arteriolosclerosis
Which age group is hyaline arteriolosclerosis usually seen in?
Elderly patients
What is the morphology of hyaline arteriolosclerosis?
- Similar change in diabetics (microangiopathy)
-
Homogeneous pink, thickening of vessels with narrowing of lumen
- Leakage of plasma across endothelium due to HTN
- Excess matrix production by the smooth muscle cells occurs secondarily

What does hyaline arteriolosclerosis typically characterize?
“Benign” nephrosclerosis
What does hyperplastic arteriolosclerosis typically characterize?
Characteristic of malignant hypertension
What is the morphology of hyperplastic arteriolosclerosis?
-
Onion-skinning
- concentric laminated walls with luminal narrowing
- Due to reduplicated basement membrane and smooth muscle cells

Malignant hypertension – morphology:
Necrotizing arteriolitis:
- term used when these changes are associated with fibrinoid necrosis
What sides of the heart does systemic and pulmonary hypertensive heart disease affect?
- Systemic hypertensive heart disease ⇒ left sided
- Pulmonary hypertensive heart disease ⇒ right sided
What type of hypertrophy is typically seen in systemic hypertensive heart disease?
- Concentric left ventricular hypertrophy in the absence of other cardiovascular pathology
- History or pathologic evidence of hypertension >140/90 mm Hg
- 25% of US population
Systemic Hypertensive Heart Disease: morphology
-
Cardiomegaly:
- Concentric hypertrophy without dilatation
- >1.5 cm wall thickness
- 500 – 600 g
- Thickness of left ventricular wall impairs diastolic filling and causes left atrial enlargement
-
Myocyte hypertrophy:
- Increased myocyte size & nuclear enlargement
What are the possible clinical outcomes for systemic hypertensive heart disease?
- Normal longevity
- Progressive ischemic heart disease
- HTN potentiates ischemic heart disease
- Progressive renal damage or stroke
- Progressive heart failure
- Sudden cardiac death
What causes Cerebral Damage in systemic hypertensive heart disease?
- Cerebral vessels affected by arteriolosclerosis are weakened and more likely to rupture, causing intracerebral hemorrhage
- Lacunar infarcts
-
Hypertensive encephalopathy
- Headaches, confusion, vomiting, convulsions
- Increased CSF pressure
How can Renal Damage differ in systemic hypertensive heart disease?
-
Benign hypertension
- Kidneys usually atrophic; granular, pitted surfaces
- Hyaline arteriolosclerosis of vessels results in ischemia and atrophy
- Glomeruli may become sclerosed
-
Malignant hypertension
- Pinpoint petechial hemorrhages on surface
- Fibrinoid necrosis of arterioles
- Hyperplastic arteriolosclerosis and microthrombi lead to global ischemia
How does pulmonary hypertension affect the ventricles?
Cor pumonale:
- right ventricular hypertrophy and/or dilatation
- failure secondary to pulmonary hypertension
Causes and morphology of acute vs. chronic pulmonary hypertension:
-
Acute: massive pulmonary embolism
- Dilatation of right ventricle without hypertrophy
-
Chronic: primary pulmonary hypertension or secondary pulmonary hypertension due to chronic lung diseases
- Right ventricular hypertrophy, up to 1 cm in thickness, secondary to pressure overload
- Obstruction of pulmonary arteries/arterioles/septal capillaries
What is congestive heart failure?
Inability of the heart to pump blood at a rate to meet the needs of active tissues
- Or can do so only from an elevated filling pressure
- poor prognosis
What does CHF usually result from?
Usually results from a slowly developing intrinsic deficit in contraction, (but occasionally occurs acutely)
What are the possible mechanisms of CHF (acute vs. chronic)?
-
Abnormal load presented to heart
- Acutely: fluid overload, MI, valve dysfunction
- Chronically: ischemic heart disease, dilated cardiomyopathy, hypertension
-
Impaired ventricular filling
- Acutely: pericarditis or tamponade
- Chronically: restrictive cardiomyopathy, severe left ventricular hypertrophy
-
Obstruction due to valve stenosis
- Chronically: rheumatic valve disease (usually mitral valve)
CHF – Systolic vs. diastolic dysfunction:
-
Systolic dysfunction: progressive deterioration of cardiac (contractile) function
- Ischemic heart disease
- Pressure or volume overload
- Dilated cardiomyopathy
-
Diastolic dysfunction: inability of heart to relax, expand, and fill sufficiently during diastole
- Massive left ventricular hypertrophy
- Amyloidosis
- Myocardial fibrosis
- Constrictive pericarditis
Describe the Frank-Starling compensatory mechanism in CHF:
-
Frank-Starling mechanism
- increased preload dilation (increased end diastolic filling volume) helps to sustain cardiac performance by enhancing contractility (lengthened fibers contract more forcibly)
- Does result in increased wall tension & oxygen requirements
Describe the activation of neurohumoral systems in CHF:
-
Release of norepinephrine by cardiac nerves:
- increase heart rate, myocardial contractility, & vascular resistance
-
Activation of RAA system:
- increased Na and water resorption, increases cardiac output and increased vasoconstriction
-
Release of atrial natriuretic peptide:
- secreted from atrial myocytes when atrium is dilated, causing vasodilation, diuresis
What is cardiac hypertrophy a response to?
Compensatory response to increased load occurring over weeks to months
- Increased numbers of sarcomeres makes fibers visibly bigger
- No hyperplasia
How can the extent of hypertrophy determine the underlying cause?
-
600 g:
- pulmonary hypertension & ischemic heart disease
-
800 g:
- systemic hypertension, aortic stenosis, mitral regurgitation, dilated cardiomyopathy
-
1000 g:
- aortic regurgitation, hypertrophic cardiomyopathy
Pressure overload vs. volume overload hypertrophy:
-
Pressure overload: concentric hypertrophy
- HTN, aortic stenosis
-
Volume overload: hypertrophy accompanied by dilatation (eccentric hypertrophy)
- Mitral or aortic regurgitation